Please wait
0001936258N/AEX-FILING FEESOrdinary Shares, nominal value euro 0.12 per share, to be issued under the ESPP000193625812026-06-052026-06-0500019362582026-06-052026-06-05xbrli:purexbrli:sharesiso4217:USD

 

Exhibit 107

CALCULATION OF FILING FEE TABLE

Form S-8

(Form Type)

NewAmsterdam Pharma Company N.V.

(Exact Name of Registrant as Specified in its Charter)

Table 1 - Newly Registered Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Security Type

 

Security Class

Title

 

Fee Calculation
Rule

 

Amount

to be

Registered (1)

 

Proposed

Maximum

Offering
Price

Per Share
 

 

Proposed

Maximum

Aggregate

Offering

Price

 

Fee Rate

 

Amount of

Registration

Fee

 

 

 

 

 

 

 

 

Equity

 

Ordinary Shares, nominal value €0.12 per share, to be issued under the ESPP

 

Rules 457(c) and 457(h)

 

1,150,000 (2)

 

$26.76(3)

 

$30,774,000

 

0.0001381

 

$4,249.89

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Offering Amounts

 

 

 

$30,774,000

 

 

 

$4,249.89

 

 

 

 

 

Total Fee Offsets

 

 

 

 

 

 

 

$0

 

 

 

 

 

Net Fee Due

 

 

 

 

 

 

 

$4,249.89

 

 

(1)

Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional ordinary shares in the share capital of NewAmsterdam Pharma Company N.V. (the “Company”), nominal value of €0.12 per share (the “Ordinary Shares”), that may become issuable under the NewAmsterdam Pharma Company N.V. 2026 Employee Stock Purchase Plan (the “ESPP”) from time to time by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of the Company’s Ordinary Shares.

 

 

(2)

Represents Ordinary Shares reserved for issuance under ESPP and registered hereby.

 

 

(3)

Estimated in accordance with Rule 457(c) and (h) under the Securities Act. The proposed maximum offering price per share and maximum aggregate offering price are calculated based on $31.48, the average of the high and low sale prices of the Company’s Ordinary Shares as reported on the Nasdaq Global Select Market on June 2, 2026. Pursuant to the ESPP, the purchase price of the Ordinary Shares reserved for issuance thereunder will be 85% of the lower of the fair market value of the Ordinary Shares on (i) the first day of the applicable offering period and (ii) the exercise date.